Cervical Cancer Screening in Average-Risk Women: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Description The purpose of this best practice advice article is to describe the indications for screening for cervical cancer in asymptomatic, average-risk women aged 21 years or older. Methods The evidence reviewed in this work is a distillation of relevant publications (including systematic reviews) used to support current guidelines. Best practice advice 1 Clinicians should not screen average-risk women younger than 21 years for cervical cancer. Best practice advice 2 Clinicians should start screening average-risk women for cervical cancer at age 21 years once every 3 years with cytology (cytologic tests without human papillomavirus [HPV] tests). Best practice advice 3 Clinicians should not screen average-risk women for cervical cancer with cytology more often than once every 3 years. Best practice advice 4 Clinicians may use a combination of cytology and HPV testing once every 5 years in average-risk women aged 30 years or older who prefer screening less often than every 3 years. Best practice advice 5 Clinicians should not perform HPV testing in average-risk women younger than 30 years. Best practice advice 6 Clinicians should stop screening average-risk women older than 65 years for cervical cancer if they have had 3 consecutive negative cytology results or 2 consecutive negative cytology plus HPV test results within 10 years, with the most recent test performed within 5 years. Best practice advice 7 Clinicians should not screen average-risk women of any age for cervica…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, less effort has been paid to systematically ensuring high rates of timely follow-up of abnormal cancer screening test results.9,10,11,12,13”
From A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical Trial (2023) · cites this paper as [10]
Citations
Cites
Screening for cervical cancer: U.S. preventive services Task force recommendation statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-12-201206190-00424 · Cited by 1,049
Arbyn, M., Kyrgiou, M., Simoens, C., Raifu, A. O., Koliopoulos, G., Martin-Hirsch, P., Prendiville, W., & Paraskevaidis, E. (2008) · BMJ · doi:10.1136/bmj.a1284 · Cited by 694
Surgery for cervical intraepithelial neoplasia
Martin-Hirsch, P. P., Paraskevaidis, E., Bryant, A., & Dickinson, H. O. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001318.pub3 · Cited by 415
Research works printed but not linked: 55
- 10.1016/j.vaccine.2012.07.056 · DOI · Paper page
- 10.1097/AOG.0b013e3182426275 · DOI
- 10.3122/jabfm.2012.06.120021 · DOI
- 10.1097/AOG.0b013e3181996ffa · DOI
- 10.1016/j.ajog.2011.07.024 · DOI · Paper page
- 10.1056/NEJMcp1210379 · DOI
- 10.1097/AOG.0b013e3182883a34 · DOI · Paper page
- 10.1111/j.1471-0528.2009.02263.x · DOI
- 10.1111/j.1471-0528.2011.02944.x · DOI · Paper page
- 10.1136/ebm.2011.100238 · DOI
- 10.1016/S0140-6736(06)68181-6 · DOI · Paper page
- Patel DA, 2013, J Registry Manag, 40, 84
- 10.1097/AOG.0000000000000174 · DOI · Paper page
- 10.1002/14651858.CD001318.pub2 · DOI · Paper page
- 10.1016/S0002-9378(03)00418-6 · DOI · Paper page
- 10.1097/AOG.0b013e31825bc6e8 · DOI
- 10.1097/AOG.0b013e318277c92a · DOI · Paper page
- 10.3322/caac.21139 · DOI · Paper page
- 10.1016/j.jcv.2004.12.008 · DOI · Paper page
- 10.1001/archinte.164.3.243 · DOI
- 10.1093/jnci/dju153 · DOI · Paper page
- 10.1016/j.ygyno.2012.01.012 · DOI · Paper page
- 10.7326/0003-4819-148-7-200804010-00013 · doi:10.7326/0003-4819-148-7-200804010-00013
- 10.1016/j.ajog.2004.09.026 · DOI
- 10.1089/jwh.2013.4475 · DOI
- 10.1097/AOG.0b013e31824e9f2f · DOI
- 10.1016/j.ajog.2011.06.001 · DOI
- 10.1001/jamainternmed.2013.368 · doi:10.1001/jamainternmed.2013.368
- 10.1097/MLR.0b013e3181ca4015 · DOI
- 10.1001/archinternmed.2010.134 · DOI
- 10.1001/archinternmed.2011.570 · DOI
- 10.1001/2013.jamainternmed.1022 · DOI
- Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, 61, 1043
- 10.1001/jama.291.24.2990 · DOI · Paper page
- 10.1016/j.ypmed.2012.10.025 · DOI
- 10.1093/jnci/djn019 · DOI · Paper page
- 10.1097/LGT.0b013e3182616241 · DOI
- Saraiya M, 2010, Am J Manag Care, 16, e137
- 10.1007/s10552-008-9228-4 · DOI · Paper page
- 10.1158/1055-9965.EPI-07-2629 · DOI · Paper page
- 10.1001/jama.287.18.2382 · DOI · Paper page
- 10.1097/01.AOG.0000120143.50098.c7 · DOI · Paper page
- 10.1001/jama.287.18.2372 · DOI · Paper page
- 10.1001/2013.jamainternmed.1034 · DOI
- 10.1097/AOG.0000000000000670 · DOI
- Merrill RM, 2008, Med Sci Monit, 14, CR24
- 10.1016/j.vaccine.2012.06.091 · DOI · Paper page
- 10.1089/jwh.2009.1673 · DOI
- 10.1001/jama.291.1.71 · DOI · Paper page
- 10.1016/j.amjmed.2004.08.021 · DOI
- 10.1007/s11606-008-0633-x · doi:10.1007/s11606-008-0633-x
- 10.1371/journal.pone.0052552 · DOI
- 10.1136/amiajnl-2011-000536 · DOI
- 10.1097/LGT.0b013e3182607137 · doi:10.1097/lgt.0b013e3182607137
- 10.1097/AOG.0000000000000669 · DOI · Paper page
Cited by
Fontham, E. T. H., Wolf, A. M. D., Church, T. R., Etzioni, R., Flowers, C. R., Herzig, A., Guerra, C. E., Oeffinger, K. C., Shih, Y. T., Walter, L. C., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21628 · Cited by 968
Cervical Cancer: Prevention and Early Detection
Kessler, T. A. (2017) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2017.02.005 · Cited by 277
Atlas, S. J., Tosteson, A. N. A., Wright, A., Orav, E. J., Burdick, T. E., Zhao, W., Hort, S. J., Wint, A. J., Smith, R. E., Chang, F. Y., et al. (2023) · JAMA · doi:10.1001/jama.2023.18755 · Cited by 54
Metadata
- Authors
- Sawaya, G. F., Kulasingam, S., Denberg, T. D., Qaseem, A., & for the Clinical Guidelines Committee of the American College of Physicians*
- Affiliations
- From the University of California, San Francisco, Center for Healthcare Value, San Francisco, California; University of Minnesota School of Public Health, Minneapolis, Minnesota; Carilion Clinic, Roanoke, Virginia; and American College of Physicians, Philadelphia, Pennsylvania.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-06-16
- Volume
- 162
- Issue
- 12
- Pages
- 851-859
- ISSN
- 0003-4819
- 1539-3704
- Cited by
- 60
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.